drugset / Trial / NCT04120363

Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations

NCT04120363

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.

Timeline

Start
2019-09-23
Primary completion
2021-07-08
Completion
2021-07-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule 750 mg Intramuscular

Indications

No indication recorded.